What is AptarGroup's pharma — total?

AptarGroup (ATR) reported pharma — total of $438.56M in Q1 2026.

How has AptarGroup's pharma — total changed year-over-year?

AptarGroup's pharma — total increased by 7.1% year-over-year, from $409.47M to $438.56M.

What does pharma — total mean?

Represents the aggregate financial performance of the business segment focused on dispensing systems for prescription drugs, consumer healthcare, and injectables. This segment is a primary growth driver for the company, reflecting its strategic focus on high-margin medical packaging solutions.

AptarGroup ATR Pharma — Total

Other segment segments

Beauty

$363.64M—

Closures

$180.67M—

Similar metrics at other companies

NPOFood and pharmaceutical — Total third-party sales

$22.4M+24.4%

BAXPharmaceuticals — Net Sales

$621M+6.9%

PFEBiopharma — Revenues:

$14.16B+5.4%

MCKPrescription Technology Solutions — Total revenues

$1.5B+11.7%

MCKNorth American Pharmaceutical — Total revenues

$79.12B+2.8%

CAHPharmaceutical and Specialty Solutions — Revenue

$56.11B+11.3%

Other financials

Income statement

See full

Revenue$982.9M+10.8%

Gross profit$351.9M+4.6%

Operating income$107.5M-5.2%

Net income$72.7M-7.8%

EPS (diluted)$1.12-4.3%

Balance sheet

See full

Cash & equivalents$225.0M+78.8%

Total debt$1.4B+32.7%

Total equity$2.6B+3.6%

Total assets$5.1B+12.6%

Cash flow

See full

Operating cash flow$118.7M+43.5%

CapEx$65.4M+15.0%

Free cash flow$53.3M+106%

Valuation

See full

Market cap$7.68B-17.9%

Enterprise value$8.89B-13.9%

P/E19.9×-5.4×

P/S2×-0.6×

Profitability

See full

Gross margin36.7%-1.6pp

Operating margin12.8%-1.2pp

Net margin10%-0.4pp

FCF margin8.4%-2.1pp

Returns & leverage

See full

Return on equity15%-0.2pp

Debt / equity0.5×+0.1×

Current ratio1.7×+0.4×

Where this comes from

Reported directly by AptarGroup in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.

The official record: AptarGroup’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about AptarGroup's pharma — total.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AptarGroup's pharma — total?: AptarGroup (ATR) reported pharma — total of $438.56M in Q1 2026.
How has AptarGroup's pharma — total changed year-over-year?: AptarGroup's pharma — total increased by 7.1% year-over-year, from $409.47M to $438.56M.
What does pharma — total mean?: Represents the aggregate financial performance of the business segment focused on dispensing systems for prescription drugs, consumer healthcare, and injectables. This segment is a primary growth driver for the company, reflecting its strategic focus on high-margin medical packaging solutions.